Exploring the Bioinformatics-Enabled 3D CAVE



It’s a triumph of three-dimensional imagery.

Bioinformatics is giving researchers an entirely different view of the human anatomy - from the top, outside and within.

The University of Calgary's Sun Centre of Excellence for Visual Genomics (COE) has pioneered the development of the world's first Java 3D-enabled Cave Automatic Virtual Environment (CAVE), which allows researchers to view, analyze and manipulate images and data in virtual reality.

"It allows the user to play with images in a pretty unprecedented [fashion]," said Dr. Andrei Turinsky, research associate at the COE. He added the center's CAVE technology is not even comparable to a regular two-dimensional screen.

CAVE technology was originally researched and developed by the Electronic Visualization Laboratory at the University of Illinois in Chicago. COE adopted the technology three years ago and modified it for use in bioinformatics.

The Calgary researchers used Java's 3D API for the CAVE's 3D component. Java is one of the major programming languages in bioinformatics and provides the added benefit of unlinking the development environment from the execution of the fully developed system, according to a COE white paper.

Developed in collaboration with Fakespace Systems Inc. and Sun Microsystems, the CAVE consists of four Marquee 8500 CRT projectors operating at a full resolution of 1280 x 1024. Users wear a pair of electronic LCD shutter glasses that operate at a frequency of 112 Hz, with rapidly alternating left and right eye perspective views. At a speed of 56 frames per second, per eye, the brain is able to "fuse" alternating pictures into one image.

"Virtually you are communicating with the object as it is moving towards you and around you. You can (either) manipulate the object using a joystick device, or you can walk around it and the CAVE tracks your movement. The object (being analyzed) stays still and you can walk into it," Turinsky said.

The CAVE provides anatomical and molecular images ranging from human organs down to the level of individual molecules such as DNA and protein.

The Sun Centre loads images provided by biologists on to the CAVE for viewing and analysis, said Turinsky. "We don’t really care what area on this hierarchy of scale we are working in, as long as we can get the pictures from the biologist, process them, visualize them and make sure they happen in the CAVE."

Currently, the CAVE can take images in various 3D, tiff, and vrml (virtual reality markup language) formats, said Turinsky. COE is working on expanding its capabilities to enable the CAVE to load volumetric data, including medical images such as MRI (magnetic resonance image) and CAT scans.

The ability to have a three-dimension view and analysis of the images in virtual reality provides benefits that two-dimensional screens cannot, said Turinsky. "Typically on a 2D screen you deal with images that look like a bowl of spaghetti, it is hard to distinguish what the parts are and where they go. In the CAVE, you will see the object like you would see it in real life, extended."

The CAVE does not only provide viewing pleasure for researchers. It runs image analysis algorithms "to create automatic measurements and quantification of anatomical issues", so when an image is placed in the CAVE the researcher could see if the algorithm is computing correctly, Turinsky said.

COE also hopes to add the element of time into the CAVE. Turinsky said the time equation would allow researchers to view images changing through time.

"If a disease (for example) takes two years (to progress), you can view the time series in two minutes. It would compress progress of a biomedical process and see it in three dimension changing through time."

The ability to provide complete and comprehensive data in a single view is another element COE wants to add to the CAVE's capabilities, according to the Calgary researcher.

By mapping different types of data into the same CAVE space, the user can view the anatomy "but at the same time you can see what genes are active or inactive at each moment and each place of your brain."

Last April, the Sun Centre received funding to undertake planned expansion of CAVE capabilities. It will be a two-year project in collaboration with graphics firm Kasterstener Publications Inc., which will develop a 3D atlas of the human anatomy, according to Turinsky.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .